Peter Mason
38Patents
7h-index
48Co-inventors
69Inventor score
Filing activity: Apr 7, 1995 → Nov 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11078237B2 | Antigen delivery platforms | Chemistry; Metallurgy | 37 | Active |
| US8252574B2 | Pseudoinfectious flavivirus and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US9273288B2 | Pseudoinfectious flavivirus and uses thereof | Emerging Cross-Sectional Technologies | 12 | Active |
| US8889623B2 | Immunostimulatory nanoparticles and related compositions, methods and systems | Emerging Cross-Sectional Technologies | 9 | Active |
| US9771414B2 | Human antibodies to ebola virus glycoprotein | Chemistry; Metallurgy | 9 | Active |
| US8883729B2 | Nanolipoprotein particles and related compositions, methods and systems | Emerging Cross-Sectional Technologies | 8 | Active |
| US9499588B2 | Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US10421804B2 | Anti-Zika virus antibodies and methods of use | Emerging Cross-Sectional Technologies | 7 | Active |
| US10081670B2 | Human antibodies to Ebola virus glycoprotein | Chemistry; Metallurgy | 7 | Active |
| US10501526B2 | Human antibodies to Ebola virus glycoprotein | Chemistry; Metallurgy | 6 | Active |
| US5824316A | Leader-proteinase deleted foot-and-mouth disease viruses and their use as vaccines | Chemistry; Metallurgy | 5 | Expired |
| US5612040A | Non-infectious foot-and-mouth disease viruses | Chemistry; Metallurgy | 4 | Expired |
| US10030231B2 | Influenza virus reassortment | Chemistry; Metallurgy | 2 | Active |
| US9708585B2 | Influenza virus reassortment | Chemistry; Metallurgy | 2 | Active |
| US10973899B2 | Flavivirus replicons | Emerging Cross-Sectional Technologies | 2 | Active |
| US11117955B2 | Anti-Zika virus antibodies and methods of use | Emerging Cross-Sectional Technologies | 1 | Active |
| US8945904B2 | Influenza virus reassortment | Chemistry; Metallurgy | 1 | Active |
| US10463748B2 | Human antibodies to S. aureus Hemolysin A toxin | Chemistry; Metallurgy | 1 | Active |
| US9072702B2 | Reverse genetics using non-endogenous pol I promoters | Chemistry; Metallurgy | 1 | Active |
| US10940211B2 | Human antibodies to S. aureus hemolysin A toxin | Chemistry; Metallurgy | 1 | Active |
| US11530255B2 | Human antibodies to Ebola virus glycoprotein | Chemistry; Metallurgy | 1 | Active |
| US9422528B2 | Influenza virus reassortment | Chemistry; Metallurgy | 1 | Active |
| US10829544B2 | Human antibodies to Ebola virus glycoprotein | Chemistry; Metallurgy | 1 | Active |
| US10500266B2 | Influenza virus reassortment | Chemistry; Metallurgy | 0 | Active |
| US10865236B2 | Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.